Keywords: Claris Lifesciences, Otsuka, Mitsue & Co, Joint venture, Infusion business, India, Emerging markets

Claris Lifesciences dips on sale of infusions business

Article | 09 December 2012

Print This

Indian drugmaker Claris Lifesciences (CLAI: BO) has dipped 4% to 264 rupees, declining over 6% from day’s high after the company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in